Project Grant K99CA300506
Award Date 5/1/26
Completion Date 4/30/28
Dollars Obligated $115K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA 22904, USA
Similar Awards
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded the University of Virginia a $291,498 Project Grant under the Cancer Research Manpower program (CFDA 93.398) on May 1, 2026, to support structured career development research investigating the impact of obesity and androgen receptor (AR) signaling on BRAF/MEK inhibitor (BRAF/MEKI) resistance in melanoma. Through this five-year award (completion date: April 30, 2031), the principal investigator will conduct research...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded Fred Hutchinson Cancer Center a $140,854 Project Grant under the Cancer Research Manpower program (CFDA 93.398) effective July 1, 2025, through December 31, 2026. This K99/R00 Pathway to Independence Award supports research training and career development for Dr. Karl Cristie Figuracion, PhD, ARNP, a postdoctoral research fellow transitioning to an independent scientist. The award funds a structured training and mentorship...
- Federal Project Grant Award Summary The National Cancer Institute awarded the University of Washington $278,494 on August 1, 2025, under the Cancer Research Manpower program (CFDA 93.398) to support a K08 Mentored Research Scientist Development Award. This five-year project, concluding July 31, 2030, funds the career development and research training of an Assistant Professor of Medicine and primary care physician to become an independent clinician investigator specializing in cancer screening...
- Federal Grant Award Summary The National Cancer Institute (CFDA 93.393 – Cancer Cause and Prevention Research) awarded the University of Virginia a $3.36 million Project Grant on September 24, 2025, to evaluate the efficacy and optimal sequencing of two evidence-based digital interventions designed to address co-occurring insomnia and depression in breast cancer survivors. The research will utilize SHUTi (an automated cognitive-behavioral therapy application for insomnia) and IntelliCare (a...
- Federal Grant Award Summary The National Cancer Institute awarded the University of Pittsburgh a $141,566 Project Grant on March 24, 2026, under the Cancer Research Manpower program (CFDA 93.398) to support biomedical research training and career development in cancer research. The grant funds research focused on understanding the conformational landscape and regulation of small GTPases (SMGs), specifically examining how oncogenic RhoA proteins function in cancer cell environments. The project...
- Federal Project Grant Award Summary The University of Virginia received a $192,888 Project Grant from the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398), effective September 1, 2025, through August 31, 2028. This award supports research aimed at identifying causal genetic variants associated with colorectal cancer risk and elucidating their mechanistic pathways. The project employs normal colon organoids as a novel research platform to distinguish true...
- Federal Grant Award Summary The National Cancer Institute awarded H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. a Project Grant under the Cancer Research Manpower program (CFDA 93.398) in the amount of $123,182.00, effective July 17, 2025, with a completion date of June 30, 2027. This award supports a Pathway to Independence Award (K99/R00) research project investigating the mechanisms by which dormant disseminated breast cancer cells communicate with their surrounding...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a $191,490 Project Grant under the Cancer Research Manpower program (CFDA 93.398) to the University of Kansas Medical Center Research Institute, Inc., effective August 1, 2025, through July 31, 2030. The award supports Dr. Forcino's research to identify and address employment concerns among cancer patients across diverse clinical settings. The project delivers three primary research products: (1) a patient-level needs and...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a Project Grant totaling $411,334 to the University of Maryland, Baltimore on March 18, 2026, under the Cancer Treatment Research program (CFDA 93.395). This research initiative, titled "Associations Between Actigraphy-Derived Circadian Rest-Activity Rhythms and Cancer-Related Fatigue: Insights from the Harvest for Health Clinical Trial," will deliver quantitative analysis of the relationship between...
- Federal Grant Award Summary The University of Kansas Medical Center Research Institute, Inc. received a $135,951 Project Grant award from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395), effective September 4, 2025, with completion targeted for August 31, 2030. This award supports a research initiative focused on enhancing access to breast cancer prevention clinical trials, addressing critical gaps in patient and provider engagement across the cancer...